Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.
| Quarter | Letter Date | Fund Name | QTD | YTD | Tickers | Themes | Quick Take |
|---|---|---|---|---|---|---|---|
Buyside Digest is not affiliated with, and does not endorse, Vulcan Value Partners - Focus. This analysis is provided for institutional research purposes only and is not investment advice.
"Vulcan Value Partners capitalized on Q2 2025 tariff-related volatility, actively reallocating capital to pick up discounted healthcare and industrial compounders, notably repurchasing UnitedHealth Group after a severe pullback."
Vulcan Value Partners recorded positive results for the second quarter of 2025. Tariff concerns and 'Liberation Day' headlines early in the quarter caused temporary market sell-offs, allowing the fund to capitalize on discounted MVP listings. Key movements included the purchase of IQVIA Holdings and Forterra plc. Additionally, the fund executed a round-trip on UnitedHealth Group, selling early in the quarter as it approached fair value, and repurchasing it later after a more than 50% price drop following negative earnings revisions and CEO resignation. Several fully-valued positions, including Heineken, Carlyle Group, and Dun & Bradstreet, were sold to fund these purchases.
Sign in or create a free account to unlock full commentary, extracted equity pitches, and direct outbound manager source links with your 3 quarterly credits.
Algorithmic conviction, macroeconomic posture, and risk appetite signals extracted from this quarterly letter with qualitative explanations.
Market Conviction
High-conviction positioning: Vulcan Value Partners capitalized on Q2 2025 tariff-related volatility, actively reallocating capital to pick up discounted healthcare and industrial compounders, notably repurchas...
Growth Outlook
Market outlook remains above average conviction: Vulcan Value Partners capitalized on Q2 2025 tariff-related volatility, actively reallocating capital to pick up discounted healthcare and industrial compounders, notably repurchas...
Risk Appetite
Risk appetite posture is above average conviction: Vulcan Value Partners capitalized on Q2 2025 tariff-related volatility, actively reallocating capital to pick up discounted healthcare and industrial compounders, notably repurchas...
Capital Deployment
Manager actively deployed capital into high-conviction opportunities. Vulcan Value Partners capitalized on Q2 2025 tariff-related volatility, actively reallocating capital to pick up discounted healthcare and industrial compounders, notably repurchas...
Forward Guidance
Forward guidance signal: Vulcan Value Partners capitalized on Q2 2025 tariff-related volatility, actively reallocating capital to pick up discounted healthcare and industrial compounders, notably repurchas...
Language Signal
Tone analysis indicates above average conviction language: Vulcan Value Partners capitalized on Q2 2025 tariff-related volatility, actively reallocating capital to pick up discounted healthcare and industrial compounders, notably repurchas...
Perceived Risk
Perceived risk level is evaluated as moderate conviction. Vulcan Value Partners capitalized on Q2 2025 tariff-related volatility, actively reallocating capital to pick up discounted healthcare and industrial compounders, notably repurchas...
Opportunity Density
Opportunity density index indicates high conviction actionable entry points. Vulcan Value Partners capitalized on Q2 2025 tariff-related volatility, actively reallocating capital to pick up discounted healthcare and industrial compounders, notably repurchas...
Time Horizon
Investment time horizon reflects a high conviction orientation. Vulcan Value Partners capitalized on Q2 2025 tariff-related volatility, actively reallocating capital to pick up discounted healthcare and industrial compounders, notably repurchas...
